Zurich Cantonal Bank
BIVV

Zurich Cantonal Bank’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Zurich Cantonal Bank’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,136
Closed -$331K – 2563
2017
Q4 		$331K Buy
6,136
+1,726
+39% +$94.4K ﹤0.01% 962
2017
Q3 		$252K Buy
4,410
+269
+6% +$15.8K ﹤0.01% 965
2017
Q2 		$249K Sell
4,141
-12,862
-76% -$732K ﹤0.01% 936
2017
Q1 		$926K Buy
+17,003
New +$838K 0.01% 795

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Zurich Cantonal Bank's BIVV Position: Q1 2018 in Review

Zurich Cantonal Bank sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 6,136 shares — an estimated $331K sold.

Zurich Cantonal Bank first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $926K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Zurich Cantonal Bank reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Zurich Cantonal Bank sold 6,136 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $331K.
  • Zurich Cantonal Bank first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Zurich Cantonal Bank's Bioverativ Inc. Common Stock position peaked at $926K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Zurich Cantonal Bank's 13F filing for Q1 2018, filed 3 May 2018.